| Original language | English (US) |
|---|---|
| Pages (from-to) | 1403-1407.e4 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 125 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2010 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. / Gao, Pei Song; Rafaels, Nicholas M.; Mu, Deguang; Hand, Tracey; Murray, Tanda; Boguniewicz, Mark; Hata, Tissa; Schneider, Lynda; Hanifin, Jon M.; Gallo, Richard L.; Gao, Li; Beaty, Terri H.; Beck, Lisa A.; Leung, Donald Y.M.; Barnes, Kathleen C.
In: Journal of Allergy and Clinical Immunology, Vol. 125, No. 6, 06.2010, p. 1403-1407.e4.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum
AU - Gao, Pei Song
AU - Rafaels, Nicholas M.
AU - Mu, Deguang
AU - Hand, Tracey
AU - Murray, Tanda
AU - Boguniewicz, Mark
AU - Hata, Tissa
AU - Schneider, Lynda
AU - Hanifin, Jon M.
AU - Gallo, Richard L.
AU - Gao, Li
AU - Beaty, Terri H.
AU - Beck, Lisa A.
AU - Leung, Donald Y.M.
AU - Barnes, Kathleen C.
N1 - Funding Information: Supported by the ADVN ( National Institutes of Health/National Institute of Allergy and Infectious Diseases contracts HHSN266200400029C and HHSN266200400033C ). K. C. B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program . Funding Information: Disclosure of potential conflict of interest: M. Boguniewicz has consulted for Unilever and has received research support from Novartis and Promius Pharma . L. Schneider has received research support from Novartis and Astellas . J. M. Hanifin has received research support from ALZA Corp, Astellas, Asubio Pharmaceuticals, Basilea, Centocor, Novartis, and Shionogi USA ; has consulted for ALZA Corp, Astellas, Basilea, Novartis, Shionogi USA, Taisho Pharmaceutical R&D, Teikoku Pharma USA, UCB, ZARS, and ZymoGenetics; and is on the Board of Directors for the National Eczema Association. L. A. Beck has consulted for Regeneron and Sanofi-Aventis, has received research support from Centocor , is on the Board of Directors for the Society of Investigative Dermatology, and is on the scientific advisory board of the National Eczema Association. D. Y. M. Leung has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases . K. C. Barnes has received research support from the NIH . The rest of the authors have declared that they have no conflict of interest.
PY - 2010/6
Y1 - 2010/6
UR - http://www.scopus.com/inward/record.url?scp=77952743818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952743818&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2010.03.016
DO - 10.1016/j.jaci.2010.03.016
M3 - Letter
C2 - 20466416
AN - SCOPUS:77952743818
VL - 125
SP - 1403-1407.e4
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 6
ER -